Targeting Interleukin 4 Receptor Α: A New Approach to the Treatment of Cutaneous Autoimmune Bullous Diseases?

Dermatologic Therapy - United Kingdom
doi 10.1111/dth.13190
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Diagnosis of Autoimmune Bullous Diseases

JDDG - Journal of the German Society of Dermatology
Dermatology
2018English

Targeting Treg Signaling for the Treatment of Autoimmune Diseases

Current Opinion in Immunology
AllergyImmunology
2015English

Dapsone in the Management of Autoimmune Bullous Diseases

Immunology and Allergy Clinics of North America
AllergyImmunology
2012English

Importance of Cooperation Between Dermatologists and Dentists in the Treatment of Autoimmune Bullous Diseases

Journal of the Japan Organization of Clinical Dermatologists
2018English

A New Approach to the Treatment of Acute Myeloid Leukaemia Targeting the Receptor for Growth Hormone-Releasing Hormone

British Journal of Haematology
Hematology
2018English

Targeting the Toll-Like Receptor/Interleukin 1 Receptor Pathway in Human Diseases: Rational Design of MyD88 Inhibitors

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Targeting the Fc Receptor in Autoimmune Disease

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2014English

Targeting Interleukin-4 Receptor With Hybrid Peptide for Effective Cancer Therapy

Molecular Cancer Therapeutics
Cancer ResearchOncology
2011English

Differentiated Approach to the Treatment of Autoimmune Ophthalmopathy

Problemy Endokrinologii
EndocrinologyMetabolismDiabetes
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy